Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Campaigners Appeal for Skyclarys Drug Approval

    2 hours ago

    2

    0

    Advocates for Friedreich's Ataxia patients are urging the HSE to approve the Skyclarys treatment before a final decision next week. The drug, which costs around €280,000 per patient annually, has been recommended against by the HSE Drugs Group despite its approval by the European Medicines Agency. Campaigners express the urgent need for treatment to improve their quality of life.
    Click here to Read more
    Prev Article
    Geely to Launch Monjaro SUV Next Year
    Next Article
    TikTok Skips Oireachtas Media Committee Hearing

    Related Health Updates:

    Comments (0)

      Leave a Comment